Ftse Mib
33.320,18
-0,52%
DAX
19.344,45
0,20%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.099,72
0,06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Otonomy Inc (OTIC) Otonomy Inc (OTIC) Notizie

OTIC

Otonomy (OTIC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OTIC
DataOraFonteTitoloSimboloCompagnia
04/04/202321:41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OTICOtonomy Inc
03/04/202312:19Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OTICOtonomy Inc
30/03/202322:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OTICOtonomy Inc
30/03/202322:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OTICOtonomy Inc
30/03/202322:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
24/02/202322:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OTICOtonomy Inc
14/02/202322:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
13/02/202322:57Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OTICOtonomy Inc
30/01/202312:38Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OTICOtonomy Inc
30/12/202222:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
29/12/202215:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OTICOtonomy Inc
27/12/202223:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OTICOtonomy Inc
22/12/202213:53GlobeNewswire Inc.Otonomy Announces Change in Stock Exchange ListingNASDAQ:OTICOtonomy Inc
19/12/202223:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OTICOtonomy Inc
19/12/202222:53GlobeNewswire Inc.Otonomy Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
10/11/202222:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OTICOtonomy Inc
10/11/202222:05GlobeNewswire Inc.Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
13/10/202213:30GlobeNewswire Inc.Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
02/08/202222:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OTICOtonomy Inc
02/08/202212:16TipRanksAnalyst Explains Why They Downgraded Their Rating on Otonomy (OTIC)NASDAQ:OTICOtonomy Inc
01/08/202213:30GlobeNewswire Inc.Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with TinnitusNASDAQ:OTICOtonomy Inc
25/07/202222:05GlobeNewswire Inc.Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
18/07/202213:30GlobeNewswire Inc.Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
18/05/202213:30GlobeNewswire Inc.Otonomy to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:OTICOtonomy Inc
12/05/202213:30GlobeNewswire Inc.Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual MeetingNASDAQ:OTICOtonomy Inc
09/05/202222:04GlobeNewswire Inc.Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
02/05/202213:30GlobeNewswire Inc.Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
25/04/202212:15TipRanksAnalysts Offer Insights on Healthcare Companies: Amryt Pharma (AMYT) and Otonomy (OTIC)NASDAQ:OTICOtonomy Inc
20/04/202213:30GlobeNewswire Inc.Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
15/03/202212:30GlobeNewswire Inc.Otonomy to Host Virtual Investor R&D Event on March 22, 2022NASDAQ:OTICOtonomy Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OTIC

La tua Cronologia

BIT
P1NRM3
BNP Paribas Issuance
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network